Eye tests may predict vision after corneal transplant
NCT ID NCT07461129
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how keratoconus, a disease that thins and bulges the cornea, affects electrical signals in the eye and brain. Researchers will measure these signals in 50 adults with different stages of keratoconus using standard eye tests. The goal is to see if these measurements can help predict how well someone might see after a corneal transplant.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors predict visual outcomes after corneal transplant for keratoconus patients.
- What could go wrong
- This is a small observational study with only 50 participants. It does not test any treatment, so it cannot directly improve patient care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 50 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Aug 2025
- Expected to finish
-
Aug 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Study participants will be : from 18 to 40 years old: 50 eyes of control patients 50 eyes of patients who had KC
- Ages
-
18 to 40 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion criteria: • Patients aged from 18 to 40 years with keratoconus of different stages Exclusion criteria: * Keratoconus Patients with any prior history of ocular procedures. * Patients with dense cataract. * Patients with retinal , vitreous problems or uveiitis . * Patients with optic nerve pathology * History of ocular medications e.g antiglaucoma * History of previous ocular surgery
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Keratoconus are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Minia university eye hospital
Minya, Minya Governorate, 61512, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Shorter eye treatment put to the test against standard crosslinking
- Shorter UV treatment for keratoconus put to the test
- Insulin eye drops put to the test for faster corneal healing
- Eye scans could spot hidden vision risk in down syndrome
- Can a new eye scanner match the gold standard for cataract surgery?
- Can a Light-Based scan reveal the health of your eyes?